FDA Orange Book · active-ingredient family
Chlorpheniramine maleate; codeine phosphate
Chlorpheniramine maleate; codeine phosphate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:TUXARIN ER · NDA 206323
1
Brand (NDA)
0
Generics (ANDA)
2
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TUXARIN ER | MAINPOINTE | NDA 206323 | — | Jun 22, 2015 |
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9066942 | Jan 03, 2032 | in 5 yr 7 mo | U-1716 |
| 9107921 | Jan 03, 2032 | in 5 yr 7 mo | Product |
Chlorpheniramine maleate; codeine phosphate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
